1.Maher D, Smeeth L, Sekajugo J. Health transition in Africa: practical policy proposals for primary care. Bulletin of the World Health Organization. 2010;88(12):943–8.
2.BeLue R, Okoror TA, Iwelunmor J, Taylor KD, Degboe AN, Agyemang C, et al. An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Globalization and Health. 2009;5(1):10.
3.Ekpenyong C, NE U, Akpan E, Samson T. Double burden, non-communicable diseases and risk factors evaluation in sub-Saharan Africa: The Nigerian experience. European Journal of Sustainable Development. 2012;1(2):249–70.
4.World Health Organisation. Noncommunicable diseases (NCD) Country profiles, Nigeria. 2018 https://www.who.int/nmh/countries/nga_en.pdf?ua = 1. ‘Accessed’ 16 Jul 2019.
5.Awosan J. Currents of Thought in African Sociology and the Global Community: How to Understand Research Findings in the Context of Sociological Perspectives. Florida: Universal Publishers; 2009.
6.Essien OE, Andy J, Ansa V, Otu AA, Udoh A. Coronary artery disease and the profile of cardiovascular risk factors in South South Nigeria: a clinical and autopsy study. Cardiology Research and Practice. 2014;2014.
7.Mendis S, Puska P, Norrving B, Organization WH. Global atlas on cardiovascular disease prevention and control: Geneva: World Health Organization; 2011.
8.Okpechi IG, Chukwuonye II, Tiffin N, Madukwe OO, Onyeonoro UU, Umeizudike TI, et al. Blood pressure gradients and cardiovascular risk factors in urban and rural populations in Abia State South Eastern Nigeria using the WHO STEPwise approach. PLOS ONE. 2013;8(9):e73403.
9.Sani MU, Wahab KW, Yusuf BO, Gbadamosi M, Johnson OV, Gbadamosi A. Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population-a cross sectional study. BMC Research Notes. 2010;3(1):11.
10.National Institutes of Health. National heart, lung and blood institute Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatmentof High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106(25):3143–421.
11.National Institute for Health and Care Excellence. Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease. Clinical guideline [CG67]. 2014 https://www.nice.org.uk/guidance/cg67. ‘Accessed’ 16 Jul 2019.
12.World Health Organisation. Prevention of cardiovascular disease. 2007 https://www.who.int/cardiovascular_diseases/guidelines/Full%20text.pdf. ‘Accessed’ 16 Jul 2019.
13.Kajinami K, Takekoshi N, Saito Y. Pitavastatin: efficacy and safety profiles of a novel synthetic HMG‐CoA reductase inhibitor. Cardiovascular Drug Reviews. 2003;21(3):199–215.
14.Kastelein JJ. Dyslipidaemia in perspective. The Lancet. 2014;384(9943):566–8.
15.Opie LH, Gersh BJ. Drugs for the Heart E-Book. Philadelphia: Elsevier Health Sciences; 2011.
16.Mann DM, Natarajan S. Inverse relationship between lipid-lowering drugs and saturated fat intake in US adults. Cardiovascular Drugs and Therapy. 2007;21(2):109–15.
17.Mann DM, Allegrante JP, Natarajan S, Montori VM, Halm EA, Charlson M. Dietary indiscretion and statin use. Mayo Clinic Proceedings. 2007;82(8):951–3.
18.Redberg RF. Statins and weight gain. JAMA internal medicine. 2014;174(7):1046.
19.Sugiyama T, Tsugawa Y, Tseng C-H, Kobayashi Y, Shapiro MF. Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins? JAMA Internal Medicine. 2014;174(7):1038–45.
20.Lytsy P, Burell G, Westerling R. Cardiovascular risk factor assessments and health behaviours in patients using statins compared to a non-treated population. International Journal of Behavioral Medicine. 2012;19(2):134–42.
21.Chiuve SE, McCullough ML, Sacks FM, Rimm EB. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation. 2006;114(2):160–7.
22.Cobb MM, Teitelbaum HS, Breslow JL. Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high-vs low-fat diets. JAMA. 1991;265(8):997–1001.
23.Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, Miller VT, et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. New England Journal of Medicine. 1993;328(17):1213–9.
24.Pickett S, Allen W, Franklin M, Peters RM. Illness beliefs in African Americans with hypertension. Western Journal of Nursing Research. 2014;36(2):152–70.
25.Coutu M-F, Dupuis G, D’Antono B, Rochon-Goyer L. Illness representation and change in dietary habits in hypercholesterolemic patients. Journal of Behavioral Medicine. 2003;26(2):133–52.
26.Diefenbach MA, Leventhal H. The common-sense model of illness representation: Theoretical and practical considerations. Journal of Social Distress and the Homeless. 1996;5(1):11–38.
27.Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. Journal of Human Hypertension. 2004;18(9):607–13.
28.Rosenstock IM. Historical origins of the health belief model. Health Education Monographs. 1974;2(4):328–35.
29.Leventhal H, Brissette I, Leventhal EA. The common-sense model of self-regulation of health and illness. In: Cameron LD, Leventhal H, editors. The Self-Regulation of Health and Behaviour. USA: Routledge; 2003. p. 42–65.
30.Anosike F, Mammah C, Ojo J, Ugbede N, Egwuda E, Azuwuike M, et al. The best of Nigeria. The Nigerian Country Book: New windows of opportunities. Lagos, Nigeria: 1st October Publications LTD; 2009.
31.Ansa V, Oyo-Ita A, Essien O. Perception of ischaemic heart diease, knowledge of and attitude to reduction of its risk factors. East African Medical Journal. 2007;84(7):318–23.
32.Muhammad S, Sani MU, Okeahialam BN. Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy. Nigerian Medical Journal. 2013;54(3):185–90.
33.Bingham SA, Welch AA, McTaggart A, Mulligan AA, Runswick SA, Luben R, et al. Nutritional methods in the European prospective investigation of cancer in Norfolk. Public Health Nutrition. 2001;4(3):847–58.
34.University of Cambridge, European Prospective Investigation of Cancer (EPIC). EPIC-Norfolk: nutritional methods- Food Frequency Questionnaire download. 2014 http://www.srl.cam.ac.uk/epic/nutmethod/FFQii.shtml. ‘Accessed’ 16th May 2019.
35.Curry SJ, Kristal AR, Bowen DJ. An application of the stage model of behavior change to dietary fat reduction. Health Education Research. 1992;7(1):97–105.
36.Department of Health and Social Care. General Practive Physical Activity Questionnaire. 2013 https://www.gov.uk/government/publications/general-practice-physical-activity-questionnaire-gppaq. ‘Accessed’ 16th May 2019.
37.Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D. The revised illness perception questionnaire (IPQ-R). Psychology & Health. 2002;17(1):1–16.
38.Hsiao C-Y, Chang C, Chen C-D. An investigation on illness perception and adherence among hypertensive patients. The Kaohsiung Journal of Medical Sciences. 2012;28(8):442–7.
39.Falola T. Culture and customs of Nigeria. Westport, USA: Greenwood Publishing Group; 2001.
40.Champion VL. Instrument development for health belief model constructs. Advances in Nursing Science. 1984;6(3):73–85.
41.Abraham C, Sheeran P. The health belief model. In: CONNER M, NORMAN P, editors. Predicting Health Behaviour. 2 ed. Berkshire, England: Open University Press; 2005. p. 28–80.
42.Field A. Discovering statistics using SPSS: and sex drugs and rock ’n’ roll. 3 ed. London: Sage publications; 2009.
43.Lofgren I, Greene G, Schembre S, Delmonico MJ, Riebe D, Clark P. Comparison of diet quality, physical activity and biochemical values of older adults either reporting or not reporting use of lipid-lowering medication. The Journal of Nutrition, Health & Aging. 2010;14(2):168–72.
44.Nigerian Heart Foundation, Federal Ministry of Health, World Health Organisation. Health behaviour monitor among Nigerian adult population. 2003 https://www.who.int/ncds/surveillance/steps/2003_STEPS_Report_Nigeria.pdf. ‘Accessed’ 16 Jul 2019.
45.Abubakari A, Bhopal R. Systematic review on the prevalence of diabetes, overweight/obesity and physical inactivity in Ghanaians and Nigerians. Public Health. 2008;122(2):173–82.
46.The Lancet Diabetes Endocrinology. Healthy lifestyle guidelines—are they good enough? The lancet Diabetes & endocrinology. 2014;2(10):765.
47.USAID, UKaid, UNICEF. National Nutrition and Health Survey (NNHS) 2018: Report-The Nutrition and Health Situation in Nigeria. 2018 https://www.unicef.org/nigeria/media/2181/file/Nigeria-NNHS–2018.pdf. ‘Accessed’ 2nd Aug 2019.
48.Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U, et al. Global physical activity levels: surveillance progress, pitfalls, and prospects. The Lancet. 2012;380(9838):247–57.
49.Ulasi II, Ijoma CK, Onodugo OD. A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria. BMC Health Services Research. 2010;10(71).
50.Ejim E, Okafor C, Emehel A, Mbah A, Onyia U, Egwuonwu T, et al. Prevalence of cardiovascular risk factors in the middle-aged and elderly population of a Nigerian rural community. Journal of Tropical Medicine. 2011;2011.
51.Dahiru T, Ejembi C. Clustering of cardiovascular disease risk‑factors in semi-urban population in Northern Nigeria. Nigerian Journal of Clinical Practice. 2013;16(4).
52.Makusidi MA, Liman HM, Yakubu A, Isah M, Jega R, Adamu H, et al. Prevalence of non-communicable diseases and its awareness among inhabitants of Sokoto metropolis: Outcome of a screening program for hypertension, obesity, diabetes mellitus and overt proteinuria. Arab Journal of Nephrology and Transplantation. 2013;6(3):189–91.
53.Unwin N, Setel P, Rashid S, Mugusi F, Mbanya J-C, Kitange H, et al. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bulletin of the World Health organization. 2001;79:947–53.
54.Bryman A. Social Research Methods. Oxford: Oxford University Press; 2008.
55.Walter M. Social Research Methods. Australia Oxford University Press; 2012.
56.Stack RJ, Bundy C, Elliott RA, New JP, Gibson JM, Noyce PR. Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2011;4:127–35.
57.Salovey P, Rothman AJ. Social Psychology of Health: Key Readings. New York and Hove: Psychology Press; 2003.
58.Dunbar-Jacob J, Schlenk EA, Caruthers D. Adherence in the management of chronic disorders. In: Christensen AJ, Antoni MH, editors. Chronic Physical Disorders: Behavioral Medicine’s Perspective. Oxford: Blackwell Publishers; 2002. p. 69–82.
59.Hekler EB, Lambert J, Leventhal E, Leventhal H, Jahn E, Contrada RJ. Commonsense illness beliefs, adherence behaviors, and hypertension control among African Americans. Journal of Behavioral Medicine. 2008;31(5):391–400.